Article info
Original Article
Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryos
- Correspondence to: Dr J-E S Hansen, Centre for Rare Diseases and Disabilities, Bredgade 25, 1260 Copenhagen K, Denmark; jesh{at}dadlnet.dk
Citation
Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryos
Publication history
- Accepted August 28, 2001
- Revised August 28, 2001
- First published April 1, 2002.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by the Journals of Medical Ethics
Other content recommended for you
- Is a consensus possible on stem cell research? Moral and political obstacles
- Artificial gametes: new paths to parenthood?
- The significance of induced pluripotent stem cells for basic research and clinical therapy
- Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies
- Reproductive cloning in humans and therapeutic cloning in primates: is the ethical debate catching up with the recent scientific advances?
- Why the apparent haste to clone humans?
- What’s in a name? Embryos, entities, and ANTities in the stem cell debate
- A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research
- The “future like ours” argument and human embryonic stem cell research
- What happened to the stem cells?